Pharmacological modulation of LMNA SRSF1-dependent splicing abrogates diet-induced obesity in mice
Author(s) -
Julien Santo,
Celia LopezHerrera,
Cécile Apolit,
Yacine Barèche,
Laure Lapasset,
Carine Chavey,
Serena Capozi,
Florence MahuteauBetzer,
Romain Najman,
Pauline Fornarelli,
Isabel C. LópezMejía,
Guillaume E. Béranger,
François Casas,
EzZoubir Amri,
Bernard Pau,
Didier Scherrer,
Jamal Tazi
Publication year - 2016
Publication title -
international journal of obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.663
H-Index - 225
eISSN - 1476-5497
pISSN - 0307-0565
DOI - 10.1038/ijo.2016.220
Subject(s) - white adipose tissue , rna splicing , adipose tissue , alternative splicing , lmna , endocrinology , gene isoform , medicine , energy homeostasis , knockout mouse , microbiology and biotechnology , biology , obesity , biochemistry , gene , lamin , rna , receptor
Bakground/Objectives:Intense drug discovery efforts in the metabolic field highlight the need for novel strategies for the treatment of obesity. Alternative splicing (AS) and/or polyadenylation enable the LMNA gene to express distinct protein isoforms that exert opposing effects on energy metabolism and lifespan. Here we aimed to use the splicing factor SRSF1 that contribute to the production of these different isoforms as a target to uncover new anti-obesity drug.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom